PCI BIOTECH HLD
PCI BIOTECH HLD operates in Diversified Metals & Mining.
PCI BIOTECH HLD (4QG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.117x
Based on the latest financial reports, PCI BIOTECH HLD (4QG) has a cash flow conversion efficiency ratio of -0.117x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.48 Million) by net assets (€46.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PCI BIOTECH HLD - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how PCI BIOTECH HLD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PCI BIOTECH HLD Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PCI BIOTECH HLD ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HILL END GOLD (H7K.SG)
STU:H7K
|
N/A |
|
Aruj Industries Ltd
KAR:ARUJ
|
N/A |
|
B-Scada Inc
PINK:SCDA
|
-0.024x |
|
Marechale Capital Plc
LSE:MAC
|
-0.059x |
|
Distil Plc
LSE:DIS
|
-0.129x |
|
Bimi International Medical Inc
OTCMKTS:BIMI
|
-0.046x |
|
PETROFRONTIER
MU:5PF
|
0.283x |
|
Lanka Credit and Business Finance Ltd
CM:LCBFN0000
|
N/A |
Annual Cash Flow Conversion Efficiency for PCI BIOTECH HLD (2016–2023)
The table below shows the annual cash flow conversion efficiency of PCI BIOTECH HLD from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €39.04 Million | €-14.97 Million | -0.383x | +62.72% |
| 2022-12-31 | €57.40 Million | €-59.04 Million | -1.029x | -71.35% |
| 2021-12-31 | €113.79 Million | €-68.31 Million | -0.600x | -46.79% |
| 2020-12-31 | €189.24 Million | €-77.39 Million | -0.409x | -24.85% |
| 2019-12-31 | €254.83 Million | €-83.47 Million | -0.328x | -258.30% |
| 2018-12-31 | €339.95 Million | €-31.08 Million | -0.091x | +87.51% |
| 2017-12-31 | €41.84 Million | €-30.62 Million | -0.732x | +73.17% |
| 2016-12-31 | €13.09 Million | €-35.69 Million | -2.728x | -- |